NYSE:TMOLife Sciences
Is Thermo Fisher’s New U.S. Bioprocess Design Center Shaping a Deeper Biopharma Strategy for TMO?
Thermo Fisher Scientific recently opened its flagship U.S. Bioprocess Design Center at its Plainville, Massachusetts site, adding 4,000 square feet of lab and training space to help customers develop and scale biologics, including vaccines and cell and gene therapies.
This expansion deepens Thermo Fisher’s end-to-end bioproduction offering by combining its full workflow of integrated, scalable solutions with onsite specialists who collaborate directly with customers to optimize processes and...